GAITHERSBURG, Md., Jan. 7, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the “Company” or “Cytomedix”) a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that Martin P. Rosendale, President and Chief Executive Officer of Cytomedix, will deliver a corporate presentation at the 4th Annual OneMedForum San Francisco 2011 Conference on Wednesday, January 12, 2011 at 8:30 a.m. Pacific time at the Sir Francis Drake Hotel in San Francisco.
